Case study shows importance of single-pill HIV-1 treatment

Case study shows importance of single-pill HIV-1 treatment

(HealthDay)—A single-pill combination HIV-1 treatment may be appropriate in certain cases, according to a case vignette published in the July 17 issue of the New England Journal of Medicine.

Monica Gandhi, M.D., M.P.H., from the University of California in San Francisco, and Rajesh T. Gandhi, M.D., from Massachusetts General Hospital in Boston, discuss the case of a 52-year-old homeless man who was diagnosed with HIV-1 infection in 2005. The patient was recently prescribed a multi-pill antiretroviral regimen, which he had not followed. The patient, who did not take other medications and had normal renal function, would take his medication if it was limited to a single pill once a day.

The authors discuss the currently available single-pill combinations marketed for HIV-1 treatment, each of which contains the same combination of one nucleotide reverse-transcriptase inhibitor and one nucleoside reverse-transcriptase inhibitor. After checking the HIV-1 genotype of the patient for drug resistance, a single-pill combination could be beneficial in this case. Tenofovir disoproxil fumarate and emtricitabine would be a reasonable option as a backbone in the single-pill combination, and any of the anchor drugs would be suitable for this patient, based on his having normal .

"The selection of a regimen should be based on potential side effects, food requirements, dosing schedule, and, possibly, anticipated adherence; cost may also be a consideration," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

US approves new HIV drug

May 21, 2011

The US Food and Drug Administration on Friday approved a new drug, Edurant, to fight HIV in combination with other antiretrovirals already on the market.

Recommended for you

Condoms 'too small' for Uganda men

43 minutes ago

Ugandan MPs have been inundated with complaints that many condoms on sale in the east African nation are too small, warning the problem is a blow to the fight against AIDS.

Withdrawal from the evolutionary race

20 hours ago

In some HIV sufferers, the immune system does not fight off the immune deficiency virus. Instead, the body tolerates the pathogen. A research team headed by ETH Zurich has now determined how strongly patients ...

The genetics of coping with HIV

Sep 16, 2014

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

User comments